Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

Canada
Food and Drugs Act
Part II
Regulations
s 30
(4)
sec_30__subsec_4__def_wto_agreement

Food and Drugs Act

law://ca/rsc/1985/f-27/sec_30__subsec_4__def_wto_agreement@2026-11-13

Version in force onWhereCanada

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

Defined terms · 30

Show every defined term

advanced therapeutic product
advertisement
analyst
Canada–United States–Mexico Agreement
clinical trial
confidential business information
contraceptive device
cosmetic
Department
device
drug
food
food for a special dietary purpose
foreign regulatory authority
General Council
General Council Decision
s statement of that date. (décision du Conseil général)
inspector
label
Minister
North American Free Trade Agreement
package
person
prescribed
sell
therapeutic product
therapeutic product authorization
TRIPS Agreement
unsanitary conditions
WTO
WTO Agreement
OMC)

ca/rsc/1985/f-27

History · 1 version

20 Apr 2018Reading

Contents

(1) The Governor in Council may make regulations for carrying…
(1.1) Classes
(1.2) Regulations — therapeutic products
(1.3) Consideration of existing information management systems
(1.4) Regulations — preventing or alleviating shortages
(1.5) Regulations — animal testing
(2) Regulations respecting drugs manufactured outside Canada
(3) Regulations — Canada–United States–Mexico Agreement and WTO Agreement
(4) Definitions
(5) Regulations to implement General Council Decision
(6) Definitions

Contents

(1) The Governor in Council may make regulations for carrying…
(1.1) Classes
(1.2) Regulations — therapeutic products
(1.3) Consideration of existing information management systems
(1.4) Regulations — preventing or alleviating shortages
(1.5) Regulations — animal testing
(2) Regulations respecting drugs manufactured outside Canada
(3) Regulations — Canada–United States–Mexico Agreement and WTO Agreement
(4) Definitions
(5) Regulations to implement General Council Decision
(6) Definitions

WTO Agreement has the meaning given to the word Agreement by subsection 2(1) of the World Trade Organization Agreement Implementation Act. (Accord sur l’OMC)

Federal laws of Canada reproduced under the Reproduction of Federal Law Order (SI/97-5); not the official version. Source: Justice Laws Website.

Key facts

Type: Act · R.S.C. 1985, c. F-27
Enacted: 23 May 2018
Last amended: 27 Mar 2025
Text current to: 1 Apr 2025
Official: Justice Laws Website

In force

This text since 20 Apr 2018

Connections

Implemented by 25: Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs; Exemption Order in Respect of Foods for a Special Dietary Purpose; Order Establishing Supplementary Rules Respecting the Sale of Natural Health Products Containing Ephedrine or Pseudoephedrine; Exemption Order in Respect of Labelling Requirements for Certain Natural Health Products; Supplementary Rules Respecting Nicotine Replacement Therapies Order; Feeds Regulations, 2024; Biocides Regulations; Marketing Authorization for Vitamin D in Yogurt and Kefir; Marketing Authorization to Permit a Lower Calcium Threshold for Exemptions from the Requirement for Prepackaged Products to Carry a Nutrition Symbol in the Case of Cheese, Yogurt, Kefir and Buttermilk; Medical Device Establishment Licence Fees Remission Order (Expedited Examination of Applications During the COVID-19 Pandemic); Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations; Marketing Authorization for Vitamin D in Milk, Goat’s Milk and Margarine; Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug); Fees in Respect of Drugs and Medical Devices Order; Cannabis Regulations; Safe Food for Canadians Regulations; Cannabis Exemption (Food and Drugs Act) Regulations; Marketing Authorization for Gluten-free Oats and Foods Containing Gluten-free Oats; Blood Regulations; Marihuana Exemption (Food and Drugs Act) Regulations; Marketing Authorization for Maximum Residue Limits for Veterinary Drugs in Foods; Marketing Authorization for Food Additives That May Be Used as Carrier or Extraction Solvents; Marketing Authorization for Food Additives That May Be Used as Anticaking Agents; Marketing Authorization for Food Additives That May Be Used as Colouring Agents; Marketing Authorization for Food Additives That May Be Used as Bleaching, Maturing or Dough Conditioning Agents
Cited by 16: Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs; Exemption Order in Respect of Foods for a Special Dietary Purpose3 provisions; Controlled Substances Regulations; Exemption Order in Respect of Labelling Requirements for Certain Natural Health Products; National Strategy for Eye Care Act; Supplementary Rules Respecting Nicotine Replacement Therapies Order2 provisions; Budget Implementation Act, 2024, No. 1; Feeds Regulations, 20242 provisions; Biocides Regulations2 provisions; Marketing Authorization for Vitamin D in Yogurt and Kefir4 provisions; Marketing Authorization to Permit a Lower Calcium Threshold for Exemptions from the Requirement for Prepackaged Products to Carry a Nutrition Symbol in the Case of Cheese, Yogurt, Kefir and Buttermilk; Vaping Products Reporting Regulations; Medical Device Establishment Licence Fees Remission Order (Expedited Examination of Applications During the COVID-19 Pandemic); Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations2 provisions; Nicotine Concentration in Vaping Products Regulations; Vaping Products Promotion Regulations
Cites 1: World Trade Organization Agreement Implementation Act